混合型肝细胞癌-胆管癌的MRI特征与LI-RADS分类:一项具有预后意义范围综述
该范围综述纳入40项研究共1767例混合型肝细胞癌-胆管癌(cHCC-CC),评估其MRI特征与LI-RADS分类。多数cHCC-CC表现为T2高信号(96%)、扩散受限(93%)、肝胆期低强化(91%)、动脉期强化(86%)及非周边廓清(83%);57%被归为LR-M,但仍有27%归为LR-5、10%归为LR-4。LR-M分类与更差预后相关,AFP与CA 19-9不一致升高提示该诊断。
要点
- cHCC-CC常见MRI特征包括T2高信号(96%)、扩散受限(93%)和肝胆期低强化(91%)。
- 多数cHCC-CC被归为LR-M(57%),但仍有27%归为LR-5、10%归为LR-4,反映HCC主导特征。
- LR-M分类的cHCC-CC预后较LR-4或LR-5更差,提示LI-RADS分类具有预后价值。
核心结论
- 超过半数cHCC-CC可按LI-RADS标准准确归为LR-M,但相当一部分被归为LR-4或LR-5,反映HCC主导特征;将cHCC-CC误分类为LR-5可能影响移植资格等管理决策。LR-M分类与更差预后相关,提示LI-RADS分类具有预后价值。未来整合影像特征与生物标志物可更好地评估cHCC-CC。
研究设计与样本
- 范围综述,遵循PRISMA-ScR方法学,检索医学研究数据库、灰色文献及纳入研究的参考文献(从建库至2024年9月),纳入40项研究共1767例cHCC-CC病例,提取MRI影像特征与LI-RADS分类数据进行定量总结,并对评估生物标志物和预后数据的研究进行亚组分析。
关键影像表现/征象
- cHCC-CC最常见MRI特征为T2高信号(96%)、扩散受限(93%)、肝胆期低强化(91%)、动脉期强化(86%)及非周边廓清(83%)。
- 44-78%的cHCC-CC显示HCC的主要LI-RADS特征,7-31%显示支持HCC的辅助特征,10-46%呈现经典与肝内胆管癌(ICC)相关的LR-M特征。
诊断标准与关键数值
- 57%的cHCC-CC被准确归为LR-M,10%归为LR-4,27%归为LR-5(后者显示HCC主导特征)。
- LR-M分类的cHCC-CC预后较LR-4或LR-5更差。
- AFP与CA 19-9值不一致升高提示cHCC-CC诊断。
临床应用与阅片要点
- 阅片时需注意cHCC-CC可表现为HCC主导特征而被归为LR-4或LR-5,误分类为LR-5可能影响移植资格等管理决策。
- LR-M分类与更差预后相关,提示LI-RADS分类具有预后价值。
- 作者认为未来整合影像特征与生物标志物可更好地评估cHCC-CC。
局限性
- 由于cHCC-CC罕见,现有文献存在相当大的异质性。
- 现有文献存在地理偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare primary liver cancer with heterogeneous radiologic and pathologic characteristics. This scoping review evaluates MRI characteristics of cHCC-CC, its classification using the Liver Imaging Reporting and Data System (LI-RADS), and its association with biomarkers and patient prognosis.
METHODS: A comprehensive search of medical research databases, grey literature, and references of included studies was performed from inception to September 2024 to identify articles evaluating cHCC-CC using MRI following PRISMA-ScR methodology. We extracted individual MRI imaging characteristics and LI-RADS categorization data to achieve a quantitative summary of the existing literature. A subgroup analysis was conducted for studies that evaluated biomarker and prognostic data.
RESULTS: Forty studies including 1767 cHCC-CC cases were evaluated. Most common MRI characteristics included T2 hyperintensity (96%), diffusion restriction (93%), hepatobiliary phase hypoenhancement (91%), arterial enhancement (86%), and non-peripheral washout (83%). Overall, 44-78% of cHCC-CCs demonstrated major LI-RADS features of HCC, 7-31% showed ancillary features that favor HCC, and 10-46% exhibited LR-M characteristics that are classically associated with intrahepatic cholangiocarcinoma (ICC). The majority of cHCC-CCs were accurately characterized as LR-M (57%), but a considerable proportion were categorized as LR-4 (10%) and LR-5 (27%), with the latter demonstrating HCC dominant features. cHCC-CC categorized as LR-M was associated with worse prognosis than those categorized as LR-4 or LR-5. Discordant alpha fetoprotein (AFP) and carbohydrate antigen 19-9 (CA 19-9) values raise suspicion for the diagnosis of cHCC-CC. Due to the rarity of cHCC-CC, there is considerable heterogeneity of the available literature and geographic bias.
CONCLUSION: Greater than half of cHCC-CCs can be accurately characterized as LR-M using LI-RADS criteria. However, a large minority are characterized as LR-4 or LR-5, reflecting dominant HCC features. Misclassification of cHCC-CCs as LR-5 can have management implications including inappropriate transplant eligibility. LR-M categorization is associated with worse outcomes, suggesting that LI-RADS categorization has prognostic value. Future integration of imaging features and biomarkers can be used to better evaluate for cHCC-CC.
引用
- Qian XJ, Ramji A, Samji K, et al. MRI features and LI-RADS categorization of combined hepatocellular-cholangiocarcinoma: a scoping review with prognostic implications. Radiol Med. 2026. PMID: 41774301. doi:10.1007/s11547-026-02192-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。